Literature DB >> 3943274

The influence of streptozotocin-induced diabetes mellitus on fluid and electrolyte handling in rats.

R A Hebden, S M Gardiner, T Bennett, I A MacDonald.   

Abstract

Intakes and urine outputs of fluid and electrolytes were measured daily in rats before, and for 3 weeks after, induction of diabetes by intraperitoneal injection of streptozotocin (STZ; 60 mg/kg); control animals received saline. Water intakes and urine outputs were increased on and after the first day after injection with STZ; after a transient period of negative water balance, fluid intakes and urine outputs increased in parallel. Food intake was reduced for the first 3 days after injection of STZ but thereafter there was a steady increase. On the final experimental day, the food intake of the diabetic group was 60% greater than that of the control group. Urinary electrolyte excretion was increased after injection of STZ; at the end of the experiment, the increase in urinary sodium excretion was similar to the increase in intake but the increase in urinary potassium excretion was less. On day 21 after injection of STZ plasma sodium concentration and packed cell volume were significantly reduced in the diabetic group but plasma potassium concentration was not. There was a difference between the measured osmolality and the calculated osmolarity of the plasma of the diabetic animals which was not seen in the controls. This difference was not due to pseudohyponatraemia, but was probably due to the presence of unidentified solutes, since there was a significant gap between the urinary osmolal and osmolar excretion in the diabetic animals that was not present in the control animals.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943274     DOI: 10.1042/cs0700111

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

1.  Pharmacological characterization of the cardiovascular responses elicited by kinin B(1) and B(2) receptor agonists in the spinal cord of streptozotocin-diabetic rats.

Authors:  F Cloutier; R Couture
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Dipyridamole prevents diabetes-induced alterations of kidney function in rats.

Authors:  V Vallon; H Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

3.  The effects of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus.

Authors:  R J Kiff; S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

4.  Chronic treatment with vascular endothelial growth factor preserves agonist-evoked vascular responses in the streptozotocin-induced diabetic rat.

Authors:  S Bardal; D Misurski; X Qiu; K Desai; J R McNeill
Journal:  Diabetologia       Date:  2006-02-23       Impact factor: 10.122

5.  The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery.

Authors:  P D Taylor; L Poston
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

6.  Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus.

Authors:  R J Kiff; S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

7.  PBMT and topical diclofenac as single and combined treatment on skeletal muscle injury in diabetic rats: effects on biochemical and functional aspects.

Authors:  Ligiane Souza Dos Santos; Joyce Camilla Saltorato; Marina Gaiato Monte; Rodrigo Labat Marcos; Rodrigo Álvaro Brandão Lopes-Martins; Shaiane Silva Tomazoni; Ernesto Cesar Pinto Leal-Junior; Rodrigo Leal de Paiva Carvalho
Journal:  Lasers Med Sci       Date:  2018-07-10       Impact factor: 3.161

8.  Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist.

Authors:  K Sakamoto; R Kikkawa; M Haneda; Y Shigeta
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.